Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
XERS: Xeris Biopharma Holdings, Inc. Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
XERS
The Story
XERS
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+23.9% / yr
Operating margin
11.4%
ROIC
12.8%
Financially safe
Stretched
Debt / equity
2.87×
Interest coverage
1.3×
Current ratio
2.12×
Valuation
Unrated
P/E ratio
114.1×
Xeris Biopharma Holdings, Inc.
XERS
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
Xeris Biopharma Holdings, Inc.
XERS
NASDAQ
·
USD
·
Closed
$8.08
−4.04%
$8.08
−$0.34 (4.04%)
52W Range
62th
pctl
Volume
0.86×
avg
Mkt Cap
1.39B
USD
P/E
114.1
TTM
Div Yield
–
ann
52W Range
62th
pctl
Volume
0.86×
avg
Market Cap
1.39B
USD
P/E Ratio
114.1
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings